| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Calcium channel blockers and prostate cancer
|
Loughlin, Kevin R.
|
|
2014
|
32 |
5 |
p. 537-538
2 p.
|
artikel
|
| 2 |
Cav1.3 channel α1D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers 1 1 This work was partially supported by grants from DoD PCRP program (W81XWH-09-1-0455) and KUMC Valk Foundation to Dr Benyi Li, and grants from China Natural Science Foundation to Dr Benyi Li (NSFC #81172427) and Dr Jun Yang (NSFC #81101927). This project was also supported by the “Chutian Scholar” program funded by Hubei Province of China dedicated to China Three Gorges University.
|
Chen, Ruibao
|
|
2014
|
32 |
5 |
p. 524-536
13 p.
|
artikel
|
| 3 |
Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma
|
de Oliveira, Daniel
|
|
2014
|
32 |
5 |
p. 601-606
6 p.
|
artikel
|
| 4 |
Clinicopathological characteristics and outcomes of surgically excised renal masses in African Americans
|
Qi, Peter
|
|
2014
|
32 |
5 |
p. 555-560
6 p.
|
artikel
|
| 5 |
Clinicopathological correlates of Gli1 expression in a population-based cohort of patients with newly diagnosed bladder cancer
|
Sverrisson, Einar F.
|
|
2014
|
32 |
5 |
p. 539-545
7 p.
|
artikel
|
| 6 |
Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4cm): An analysis of the SEER database
|
Daugherty, Michael
|
|
2014
|
32 |
5 |
p. 549-554
6 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2014
|
32 |
5 |
p. i-
1 p.
|
artikel
|
| 8 |
Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy
|
Klatte, Tobias
|
|
2014
|
32 |
5 |
p. 625-630
6 p.
|
artikel
|
| 9 |
Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection
|
Espiritu, Patrick N.
|
|
2014
|
32 |
5 |
p. 619-624
6 p.
|
artikel
|
| 10 |
Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy—Resistant prostate cancer cell line, PC3
|
Ding, Huan
|
|
2014
|
32 |
5 |
p. 720-726
7 p.
|
artikel
|
| 11 |
Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: A registry-based analysis 1 1 T.B. and B.M. received honoraria for advisory boards and lectures from Novartis and Pfizer. K.K. received honoraria for advisory boards and lectures from Novartis. Other authors have declared no conflict of interest. The RENIS registry is funded in part by pharmaceutical companies producing targeted agents for renal cancer (Pfizer, Bayer, GSK, Roche, and Novartis).
|
Buchler, Tomas
|
|
2014
|
32 |
5 |
p. 569-575
7 p.
|
artikel
|
| 12 |
Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States 1 1 Funding source: The US Office of Management and Budget (0925-0046).
|
Apolo, Andrea B.
|
|
2014
|
32 |
5 |
p. 637-644
8 p.
|
artikel
|
| 13 |
Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy
|
Hofner, Thomas
|
|
2014
|
32 |
5 |
p. 678-686
9 p.
|
artikel
|
| 14 |
Expression of human chorionic gonadotropin in testicular germ cell tumors
|
Lempiäinen, Anna
|
|
2014
|
32 |
5 |
p. 727-734
8 p.
|
artikel
|
| 15 |
Expression profile of CD44s, CD44v6, and CD44v10 in localized prostate cancer: Effect on prognostic outcomes following radical prostatectomy
|
Tei, Hiromoto
|
|
2014
|
32 |
5 |
p. 694-700
7 p.
|
artikel
|
| 16 |
Kidney cancer cells secrete IL-8 to activate Akt and promote migration of mesenchymal stem cells
|
Liang-kuan, Bi
|
|
2014
|
32 |
5 |
p. 607-612
6 p.
|
artikel
|
| 17 |
Masthead
|
|
|
2014
|
32 |
5 |
p. IFC-
1 p.
|
artikel
|
| 18 |
Minimal changes in the systemic immune response after nephrectomy of localized renal masses 1 1 This work was supported by the University of Iowa Carver College of Medicine/Department of Urology Investigator Start-up Funds, NIH Grant CA181088-01 (to L.A.N.), and NIH Grant CA109446 (to T.S.G.).
|
Wald, Gal
|
|
2014
|
32 |
5 |
p. 589-600
12 p.
|
artikel
|
| 19 |
MTDH/AEG-1 contributes to central features of the neoplastic phenotype in bladder cancer
|
Nikpour, Mahnaz
|
|
2014
|
32 |
5 |
p. 670-677
8 p.
|
artikel
|
| 20 |
NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder
|
Potretzke, Aaron
|
|
2014
|
32 |
5 |
p. 631-636
6 p.
|
artikel
|
| 21 |
Population-based analysis of factors associated with survival in patients undergoing cytoreductive nephrectomy in the targeted therapy era
|
Culp, Stephen H.
|
|
2014
|
32 |
5 |
p. 561-568
8 p.
|
artikel
|
| 22 |
Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: Prognostic value in invasive urothelial carcinoma of the bladder
|
Ahmadi, Hamed
|
|
2014
|
32 |
5 |
p. 648-656
9 p.
|
artikel
|
| 23 |
Prognostic effect of serum and tissue YKL-40 levels in bladder cancer
|
Tschirdewahn, Stephan
|
|
2014
|
32 |
5 |
p. 663-669
7 p.
|
artikel
|
| 24 |
PSA response to neoadjuvant androgen deprivation is an independent prognostic marker and may identify patients who benefit from treatment escalation
|
McDonald, Andrew M.
|
|
2014
|
32 |
5 |
p. 687-693
7 p.
|
artikel
|
| 25 |
Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: A comorbidity-controlled competing-risks model
|
Patel, Hiten D.
|
|
2014
|
32 |
5 |
p. 576-583
8 p.
|
artikel
|
| 26 |
Significance of circulating matrix metalloproteinase-9 to tissue inhibitor of metalloproteinases-2 ratio as a predictor of disease progression in patients with metastatic renal cell carcinoma receiving sunitinib 1 1 This study was partially supported by Pfizer Inc.
|
Miyake, Hideaki
|
|
2014
|
32 |
5 |
p. 584-588
5 p.
|
artikel
|
| 27 |
Table of Contents
|
|
|
2014
|
32 |
5 |
p. ii-v
nvt p.
|
artikel
|
| 28 |
The clinical presentation and outcome of urothelial atypia on biopsy of the bladder
|
Ziemba, Justin B.
|
|
2014
|
32 |
5 |
p. 645-647
3 p.
|
artikel
|
| 29 |
The hedgehog pathway: Potential biomarker and therapeutic applications in urologic malignancies
|
Loughlin, Kevin R.
|
|
2014
|
32 |
5 |
p. 546-548
3 p.
|
artikel
|
| 30 |
The prognostic significance of Gleason scores in metastatic prostate cancer
|
Rusthoven, Chad G.
|
|
2014
|
32 |
5 |
p. 707-713
7 p.
|
artikel
|
| 31 |
The role of microRNA in castration-resistant prostate cancer
|
Thieu, William
|
|
2014
|
32 |
5 |
p. 517-523
7 p.
|
artikel
|
| 32 |
The role of microRNA profiling in prognosticating progression in Ta and T1 urinary bladder cancer
|
Segersten, Ulrika
|
|
2014
|
32 |
5 |
p. 613-618
6 p.
|
artikel
|
| 33 |
The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder 1 1 Funding: Supported by the Sidney Kimmel Center for Prostate and Urologic Cancer and the Michael and Zea Wiener Foundation. Dr Sfakianos is a research fellow in urologic oncology supported by NIH T32-CA82088.
|
Sfakianos, John P.
|
|
2014
|
32 |
5 |
p. 657-662
6 p.
|
artikel
|
| 34 |
Underutilization of local salvage therapy after radiation therapy for prostate cancer 1 1 Funding: UBC Summer Student Research Program.
|
Tran, Henry
|
|
2014
|
32 |
5 |
p. 701-706
6 p.
|
artikel
|
| 35 |
Urinary nerve growth factor as an oncologic biomarker for prostate cancer aggressiveness
|
Liss, Michael A.
|
|
2014
|
32 |
5 |
p. 714-719
6 p.
|
artikel
|
Tijdschrift beschrijving